XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
XBiotech Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.00−0.12 (-5.66%)
Close on Oct 19, 2026
- Market cap
- $60.98M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
6.5%
2M of 30M shares
Institutional holders
36
4 new, 3 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| John Simard | 5,719,775 | 17.70% | 13G (passive) amendment | Dec 31, 2025 |
| Thomas Gut | 3,914,111 | – | 13G (passive) amendment | Dec 31, 2023 |
| W. Thorpe McKenzie | 3,006,259 | 9.76% | 13G (passive) amendment | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of XBIT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 321,146 | 1.05% | $738.64K | +28,042 | 0.00% |
| Geode Capital Management, LLC | 214,116 | 0.70% | $492.76K | −16,904 | 0.00% |
| Vanguard Capital Management LLC | 200,182 | 0.66% | $460.42K | −789 | 0.00% |
| RBF Capital, LLC | 198,501 | 0.65% | $456.55K | – | 0.02% |
| Morgan Stanley | 147,880 | 0.49% | $340.12K | −17,674 | 0.00% |
| Bridgeway Capital Management, LLC | 98,447 | 0.32% | $226.43K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 92,365 | 0.30% | $212.44K | +789 | 0.00% |
| Millennium Management LLC | 79,330 | 0.26% | $182.46K | −26,210 | 0.00% |
| State Street Corp | 73,006 | 0.24% | $167.91K | – | 0.00% |
| Northern Trust Corp | 66,258 | 0.22% | $152.39K | −9,829 | 0.00% |
| Empowered Funds, LLC | 59,547 | 0.20% | $136.96K | – | 0.00% |
| Renaissance Technologies LLC | 41,663 | 0.14% | $95.83K | +19,225 | 0.00% |
| Bank of New York Mellon Corp | 39,355 | 0.13% | $90.52K | – | 0.00% |
| Dimensional Fund Advisors LP | 36,053 | 0.12% | $82.99K | – | 0.00% |
| Squarepoint Ops LLC | 34,757 | 0.11% | $79.94K | −6,457 | 0.00% |
| Qube Research & Technologies Ltd | 33,570 | 0.11% | $77.21K | +14,879 | 0.00% |
| Gsa Capital Partners Llp | 30,654 | 0.10% | $71 | New | 0.00% |
| Citadel Advisors LLC | 29,192 | 0.10% | $67.14K | New | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 27,943 | 0.09% | $64.27K | −720 | 0.00% |
| Bnp Paribas Arbitrage, Snc | 26,464 | 0.09% | $60.87K | −700 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 36 | 2M | 6.5% | 4 / 5 | 12 / 3 | 0M | 0M |
| Q1 2026 | 37 | 2M | 6.5% | 6 / 8 | 13 / 8 | 0M | 1M |
| Q4 2025 | 41 | 2M | 8.2% | 4 / 9 | 16 / 8 | 1M | 1M |
| Q3 2025 | 48 | 3M | 9.6% | 4 / 10 | 23 / 9 | 0M | 1M |
| Q2 2025 | 53 | 3M | 11.2% | 16 / 12 | 19 / 18 | 1M | 2M |
| Q1 2025 | 55 | 4M | 14.7% | 9 / 9 | 22 / 6 | 0M | 0M |
| Q4 2024 | 53 | 5M | 15.5% | 10 / 18 | 12 / 7 | 0M | 0M |
| Q3 2024 | 50 | 5M | 15.9% | 10 / 23 | 6 / 5 | 2M | 0M |
| Q2 2024 | 46 | 5M | 14.8% | 13 / 18 | 10 / 12 | 2M | 1M |
| Q1 2024 | 46 | 4M | 14.1% | 10 / 16 | 10 / 3 | 1M | 0M |
| Q4 2023 | 39 | 4M | 11.7% | 5 / 15 | 8 / 3 | 0M | 0M |
| Q3 2023 | 37 | 3M | 11.0% | 3 / 9 | 10 / 4 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of XBIT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 200,182 | 0.66% | $460.42K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 110,502 | 0.36% | $267.41K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 78,591 | 0.26% | $180.76K | 0.01% | Jun 30, 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 59,547 | 0.20% | $136.96K | 0.01% | Jun 30, 2026 |
| Ultra-Small Company Fund | 38,900 | 0.13% | $89.47K | 0.09% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 35,154 | 0.12% | $85.07K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 27,507 | 0.09% | $66.57K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 16,960 | 0.06% | $41.04K | 0.00% | May 31, 2026 |
| Avantis U.S. Small Cap Equity ETF | 13,228 | 0.04% | $32.01K | 0.00% | May 31, 2026 |
| JNL/DFA U.S. Small Cap Fund | 6,066 | 0.02% | $13.95K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 5,290 | 0.02% | $12.17K | 0.01% | Jun 30, 2026 |
| Avantis U.S. Small Cap Value ETF | 4,871 | 0.02% | $11.79K | 0.00% | May 31, 2026 |
| AST Small-Cap Equity Portfolio | 2,660 | 0.01% | $6.12K | 0.00% | Jun 30, 2026 |
| Avantis U.S. Small Cap Value Fund | 282 | 0.00% | $682 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John Simard | Chief Executive Officer, Director, 10% owner | 3,823,166 | 12.54% | Mar 19, 2025 |
| David Spencer Soffer | Director | – | – | Nov 12, 2025 |
| Thomas Martin Kuendig | Director | 300,000 | 0.98% | Nov 12, 2025 |
| Tevi David Troy | Director | – | – | Nov 12, 2025 |
| Craig Evan Rademaker | Director | 170,985 | 0.56% | Nov 12, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| W. Thorpe McKenzie Director, 10% owner | Dec 16, 2021 | Option exercise | +250,000 | $10.00 | $2.50M | 2,810,964 |
| W. Thorpe McKenzie Director, 10% owner | Dec 16, 2021 | Tax withholding | −213,493 | $11.71 | $2.50M | 2,597,471 |
| John Simard Chief Executive Officer, Director, 10% owner | Oct 18, 2021 | Sale | −33,000 | $13.07 | $431.31K | 3,823,166 |
| John Simard Chief Executive Officer, Director, 10% owner | Oct 15, 2021 | Sale | −17,000 | $13.32 | $226.44K | 3,856,166 |
| John Simard Chief Executive Officer, Director, 10% owner | Oct 14, 2021 | Sale | −21,125 | $12.90 | $272.51K | 3,873,166 |
| John Simard Chief Executive Officer, Director, 10% owner | Oct 13, 2021 | Sale | −10,875 | $12.83 | $139.53K | 3,962,452 |
| John Simard Chief Executive Officer, Director, 10% owner | Oct 12, 2021 | Sale | −18,000 | $12.77 | $229.86K | 3,973,166 |
| John Simard Chief Executive Officer, Director, 10% owner | Oct 7, 2021 | Sale | −39,286 | $12.45 | $489.11K | 3,923,166 |
| John Simard Chief Executive Officer, Director, 10% owner | Oct 6, 2021 | Sale | −10,714 | $12.53 | $134.25K | 3,962,452 |
| John Simard Chief Executive Officer, Director, 10% owner | Oct 5, 2021 | Sale | −14,218 | $12.66 | $180.00K | 3,973,166 |
| John Simard Chief Executive Officer, Director, 10% owner | Oct 4, 2021 | Sale | −23,681 | $13.08 | $309.75K | 3,987,384 |
| John Simard Chief Executive Officer, Director, 10% owner | Oct 1, 2021 | Sale | −19,684 | $13.23 | $260.42K | 4,011,065 |
| John Simard Chief Executive Officer, Director, 10% owner | Sep 30, 2021 | Sale | −18,558 | $13.07 | $242.55K | 4,030,749 |
| John Simard Chief Executive Officer, Director, 10% owner | Sep 29, 2021 | Sale | −16,396 | $13.41 | $219.87K | 4,049,307 |
| John Simard Chief Executive Officer, Director, 10% owner | Sep 28, 2021 | Sale | −6,263 | $14.27 | $89.37K | 4,065,703 |
| John Simard Chief Executive Officer, Director, 10% owner | Sep 27, 2021 | Sale | −29,890 | $14.81 | $442.67K | 4,071,966 |
| John Simard Chief Executive Officer, Director, 10% owner | Sep 24, 2021 | Sale | −11,418 | $14.49 | $165.45K | 4,101,856 |
| John Simard Chief Executive Officer, Director, 10% owner | Sep 23, 2021 | Sale | −9,892 | $14.68 | $145.21K | 4,113,274 |
| John Simard Chief Executive Officer, Director, 10% owner | Sep 22, 2021 | Sale | −19,669 | $15.14 | $297.79K | 4,123,166 |
| John Simard Chief Executive Officer, Director, 10% owner | Sep 21, 2021 | Sale | −16,860 | $15.24 | $256.95K | 4,142,835 |
| John Simard Chief Executive Officer, Director, 10% owner | Sep 20, 2021 | Sale | −13,471 | $15.06 | $202.87K | 4,159,695 |
| John Simard Chief Executive Officer, Director, 10% owner | Jul 14, 2021 | Sale | −50,000 | $18.15 | $907.50K | 4,173,166 |
| Peter Libby Director | Jul 9, 2021 | Option exercise | +25,000 | $7.76 | $194.00K | 25,000 |
| Donald H. MacAdam Director | Jul 9, 2021 | Option exercise | +10,000 | $4.40 | $44.00K | 10,000 |
| John Simard Chief Executive Officer, Director, 10% owner | Mar 22, 2021 | Option exercise | +500,000 | $7.50 | $3.75M | 4,223,166 |
| Street Financial S.A. Bay 10% owner | Dec 18, 2020 | Sale | −1,173,033 | $18.78 | $22.03M | 1,981,515 |
| Street Financial S.A. Bay 10% owner | Dec 2, 2020 | Sale | −182,836 | $18.42 | $3.37M | 3,154,548 |
| W. Thorpe McKenzie Director, 10% owner | Nov 19, 2020 | Sale | −375,000 | $18.30 | $6.86M | 2,560,964 |
| John Simard Chief Executive Officer, Director, 10% owner | Sep 18, 2020 | Other | −500,000 | – | – | 3,723,166 |
| Sushma Shivaswamy Chief Scientific Officer | Sep 15, 2020 | Sale | −20,668 | $20.00 | $413.36K | 0 |
| Sushma Shivaswamy Chief Scientific Officer | Sep 15, 2020 | Option exercise | +20,668 | $7.50 | $155.01K | 20,668 |
| Sushma Shivaswamy Chief Scientific Officer | Sep 10, 2020 | Option exercise | +19,332 | $7.50 | $144.99K | 19,332 |
| Sushma Shivaswamy Chief Scientific Officer | Sep 10, 2020 | Sale | −19,332 | $20.01 | $386.83K | 0 |
| Queena Han VP Finance & HR | Sep 1, 2020 | Option exercise | +30,000 | $4.24 | $127.20K | 30,000 |
| Queena Han VP Finance & HR | Sep 1, 2020 | Option exercise | +27,692 | $4.16 | $115.20K | 57,692 |
| Queena Han VP Finance & HR | Aug 24, 2020 | Sale | −5,000 | $19.65 | $98.25K | 0 |
| Queena Han VP Finance & HR | Aug 24, 2020 | Option exercise | +18,700 | $7.50 | $140.25K | 18,700 |
| Queena Han VP Finance & HR | Aug 24, 2020 | Sale | −18,700 | $19.65 | $367.46K | 0 |
| Queena Han VP Finance & HR | Aug 24, 2020 | Option exercise | +12,308 | $4.16 | $51.20K | 12,308 |
| Queena Han VP Finance & HR | Aug 24, 2020 | Sale | −12,500 | $19.65 | $245.62K | 0 |
| Queena Han VP Finance & HR | Aug 24, 2020 | Option exercise | +3,333 | $4.14 | $13.80K | 3,333 |
| Queena Han VP Finance & HR | Aug 24, 2020 | Sale | −3,333 | $19.65 | $65.49K | 0 |
| Queena Han VP Finance & HR | Aug 24, 2020 | Option exercise | +12,500 | $5.26 | $65.75K | 12,500 |
| Queena Han VP Finance & HR | Aug 24, 2020 | Sale | −12,308 | $19.65 | $241.85K | 0 |
| Queena Han VP Finance & HR | Aug 24, 2020 | Option exercise | +5,000 | $15.00 | $75.00K | 5,000 |
| Queena Han VP Finance & HR | Aug 17, 2020 | Sale | −1,300 | $19.30 | $25.09K | 0 |
| Queena Han VP Finance & HR | Aug 17, 2020 | Option exercise | +1,300 | $7.50 | $9.75K | 1,300 |
| Street Financial S.A. Bay 10% owner | Feb 19, 2020 | Sale | −1,662,616 | $6.38 | $10.61M | 3,337,384 |
| John Simard Chief Executive Officer, Director, 10% owner | Feb 12, 2020 | Returned to company | −2,103,894 | $30.00 | $63.12M | 4,223,166 |
| W. Thorpe McKenzie Director, 10% owner | Feb 12, 2020 | Returned to company | −15,874 | $30.00 | $476.22K | 31,864 |
| W. Thorpe McKenzie Director, 10% owner | Feb 12, 2020 | Returned to company | −33,252 | $30.00 | $997.56K | 66,748 |
| W. Thorpe McKenzie Director, 10% owner | Feb 12, 2020 | Returned to company | −3,825 | $30.00 | $114.75K | 7,676 |
| W. Thorpe McKenzie Director, 10% owner | Feb 12, 2020 | Returned to company | −1,462,636 | $30.00 | $43.88M | 2,935,964 |
| Jan-Paul Waldin Director | Feb 12, 2020 | Returned to company | −99,757 | $30.00 | $2.99M | 200,243 |
| Thomas Gut 10% owner | Feb 12, 2020 | Returned to company | −1,949,929 | $30.00 | $58.50M | 3,914,111 |
| Thomas Gut 10% owner | Feb 12, 2020 | Returned to company | −1,947,584 | $30.00 | $58.43M | 3,916,456 |
| Thomas Gut 10% owner | Feb 12, 2020 | Returned to company | −1,868,870 | $30.00 | $56.07M | 3,995,170 |
| W. Thorpe McKenzie Director, 10% owner | Feb 12, 2020 | Returned to company | −15,214 | $30.00 | $456.42K | 32,524 |
| W. Thorpe McKenzie Director, 10% owner | Feb 12, 2020 | Returned to company | −1,401,856 | $30.00 | $42.06M | 2,996,744 |
| W. Thorpe McKenzie Director, 10% owner | Feb 12, 2020 | Returned to company | −3,665 | $30.00 | $109.95K | 7,835 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.